| Revenue | 237.07a | 225.32a |
| Cost of sales | -201.54a | -197.77a |
| Gross profit | 35.53a | 27.55a |
| Selling and distribution expenses | -0.45a | -0.43a |
| General and administrative expenses | -7.29a | -5.91a |
| Research and development expenses | -3.06a | -3.73a |
| Impairment losses on property, plant and equipment | -2.1a | -0.6a |
| Impairment reversals of financial assets | 0.13a | 0.15a |
| Other income | 1.04a | 0.68a |
| Other gains/(losses), net | 0.28a | -0.09a |
| Operating profit | 24.08a | 17.61a |
| Finance income | 0.37a | 0.4a |
| Finance costs | -3a | -3.34a |
| Finance costs, net | -2.63a | -2.94a |
| Share of net profits of investment accounted for using the equity method | — | — |
| Joint ventures | 0.78a | 0.19a |
| Associates | 0.09a | 0.2a |
| Profit before income tax | 22.32a | 15.06a |
| Income tax expense | -2.94a | -2.51a |
| Profit for the year | 19.38a | 12.56a |
| Profit attributable to | — | — |
| Owners of the company | 12.4a | 6.69a |
| Non-controlling interests | 6.98a | 5.87a |